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Introduction 
Angiolymphoid hyperplasia with eosinophilia (ALHE) 
is a rare vascular tumor with a tendency to occur in 
the head and neck of middle-aged adults. Although 
benign, the tumor may cause pain, bleeding, or 
pruritus. Surgical excision is considered the most 
effective treatment from amongst many options, but 
treatment failure still exceeds 40% with surgery. We 
present a case of ALHE treated with Mohs 
micrographic surgery. 
 
Case Synopsis 
A 60-year-old healthy man presented to the 
dermatology clinic with a 6-month history of several 
enlarging nodules of the ear. The lesions were 
enlarging, tender, spontaneously bleeding, and 
episodically pruritic. The only attempted treatment 
was with oral cephalosporins, which was ineffective.  
Physical examination revealed five agminated pink-
red papulonodules of the superior postauricular 
sulcus, the largest of which was over one centimeter 
in diameter. Several of the lesions were eroded 
(Figure 1). The clinical differential diagnosis was 
broad but most suggestive of cutaneous lymphoma 
or angiolymphoid hyperplasia. 
A skin biopsy was performed and revealed a lobular 
dermal vascular proliferation (Figure 2). The vessels 
were lined by plump endothelial cells exhibiting 
protrusion into the lumen. A dense perivascular 
Abstract 
A 60-year-old healthy man presented with several 
enlarging, tender, spontaneously bleeding, and 
episodically pruritic nodules on his ear. Five 
agminated pink-red papulonodules of the superior 
postauricular sulcus were noted on examination. 
Pathological examination revealed a lobular dermal 
vascular proliferation with plump endothelial cells 
protruding into the lumen in a hobnail pattern, along 
with a dense perivascular inflammatory infiltrate 
composed of plasma cells, lymphocytes, and 
numerous eosinophils. The diagnosis of 
angiolymphoid hyperplasia with eosinophilia was 
confirmed. After discussing treatment modalities, the 
patient opted for Mohs micrographic surgery (MMS). 
Three stages of MMS were able to remove all large 
vessel involvement and clear the peripheral margins, 
but the tumor had a complex branching pattern of 
growth in the deep bed of the wound with numerous 
tiny foci remaining. Owing to risk of disfigurement, 
no further excision was undertaken. The area was 
reconstructed with a temporalis fascia flap and a full-
thickness skin graft. Despite remaining microscopic 
disease, the patient remained without recurrence or 
symptoms at one year of follow up. 
 
Figure 1. Pink-red papulonodules noted in the left ear and 
postauricular sulcus on initial presentation of the patient. 
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inflammatory infiltrate of plasma cells, lymphocytes, 
and numerous eosinophils was noted. The 
pathologic diagnosis was angiolymphoid 
hyperplasia with eosinophilia (ALHE).  
Owing to enlargement and symptoms the patient 
opted for treatment.  After discussing options, the 
patient elected to proceed with surgical resection. 
Mohs micrographic surgery (MMS) was suggested as 
potential way to avoid recurrence. At surgery the 
patient presented with a deeply seated, multi-
lobulated mass behind the left ear. In two foci, 
papules had penetrated through the triangular fossa 
to the anterior ear. 
A first stage of MMS was carried out to the fascia. The 
lesion was grossly transected and visualized as a 
semi-encapsulated worm-like mass. Histology of the 
first stage revealed nodular aggregates of vessels 
with dense inflammation characterized by numerous 
eosinophils. A second stage of MMS was carried out 
deeply into the postauricular sulcus. The lesion was 
seen visibly tracking down a posterior superior 
auricular artery and through two small foramina in 
the cartilage of the triangular fossa (Figure 3). A third 
stage of MMS removed all large vessel involvement 
and created a transmural wound of the ear. Although 
all peripheral margins and larger vessels had been 
cleared, the deep bed of the wound still contained 
widely-scattered tiny foci of inflammation. Given 
that ALHE is benign and that further resection would 
have been highly-disfiguring, MMS was halted. The 
ear was reconstructed with a temporalis fascia flap 
and a full-thickness skin graft (Figure 4). At one year 
the patient healed well and was symptom and 
recurrence free (Figure 5).  
 
Case Discussion 
Angiolymphoid hyperplasia with eosinophilia has an 
unclear etiology hypothesized to be related to 
trauma, elevated estrogen levels, or arteriovenous 
shunting given presence of mural damage of large 
vessels in some patients [1, 2]. Angiolymphoid 
hyperplasia with eosinophilia occurs primarily in 
middle-aged adults with an Asian racial predilection 
[3]. Approximately 82% of cases occur on the head 
and neck [3]. Angiolymphoid hyperplasia with 
eosinophilia may present with itching (36%), 
 
Figure 3. Intra-operative photo showing residual foci of 
angiolymphoid hyperplasia with eosinophilia deeply seated into 
the postauricular sulcus. 
Figure 2. Hematoxylin and eosin stain consistent with 
angiolymphoid hyperplasia with eosinophilia. 
 
Figure 4. Reconstruction completed with a temporalis fascia flap 
and a full-thickness skin graft. 
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bleeding (25%), and pain (20%), [3]. The differential 
diagnosis of ALHE includes lymphoma cutis, 
sarcoidosis, basal cell carcinoma, Merkel cell 
carcinoma, angiosarcoma, or metastasis [3, 4]. 
Angiolymphoid hyperplasia with eosinophilia is 
characterized histologically by well-circumscribed 
lobular proliferations in the dermis and 
subcutaneous tissue [2, 4]. The proliferations include 
capillary-sized vessels surrounding larger central 
blood vessels [2]. The vessels in ALHE are typified by 
a “hobnail” or cobblestone appearance formed by 
the protrusion of large endothelial cells into the 
lumen of the vessel [2]. Between and among these 
vessels is a dense mixed inflammatory infiltrate with 
lymphocytes and predominant eosinophils, and may 
include mast cells and plasma cells [2].  
A myriad of treatment modalities have been 
reviewed in the literature for ALHE. A review 
including 908 cases of ALHE found that treatment 
failure, defined by the authors as incomplete 
resolution or recurrence after treatment, was 40.8% 
with excision, 50.0% with pulsed dye laser, 54.6% 
with carbon dioxide laser, and 66.7% with argon laser 
[3]. The treatment modalities with the highest failure 
rates were intralesional corticosteroids (79.1%), 
cryotherapy (80.5%), systemic corticosteroids 
(87.8%), and topical corticosteroids (98.2%), [3]. 
Clearly, the most common and effective treatment 
remains standard surgical excision, which was used 
in 44.2% of these cases with a failure rate of 40.8% [3]. 
There is a single case report of MMS being used 
successfully to treat a patient with ALHE with no 
recurrence at eight months [5]. 
The high rate of failure in the cases treated with 
surgical excision can be explained by difficulty in 
identifying margins in what is a complex branching 
vascular proliferation. These findings suggest MMS 
could be a more definitive treatment for ALHE. The 
extensive growth pattern found in our case of ALHE 
suggests why simple excision may not be curative. 
Interestingly, although we left scattered, multifocal 
microscopic disease, our patient has not experienced 
recurrence. Since the natural history of ALHE is 
poorly understood we will follow him clinically for at 
least five years. 
 
Conclusion 
This case is presented to demonstrate that MMS may 
be used to map out and resect ALHE and that the 
extent of disease may be striking. Our case also 
suggests that complete microscopic cure may not be 
essential but long term follow up of our patient will 
be necessary.   
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Figure 5. The patient remains symptom and disease free at one 
year follow up. 
